Ten‐Year Outcomes of Anticholinergic Use Among Older Adults With Intellectual Disability: Findings From the Intellectual Disability Supplement to the Irish Longitudinal Study on Ageing (IDS‐TILDA)
Older adults with intellectual disability are exposed to high anticholinergic burden at the two time points, 10 years apart. Being exposed to anticholinergics at Wave 1 is significantly associated with a higher risk of falls and reporting mental health conditions at Wave 4. A review of antipsychotic prescribing practice is urgently needed to reduce the anticholinergic exposure and its adverse outcomes among older adults with intellectual disability.
Authors
- Philip McCallion (ORCID: https://orcid.org/0000-0001-5129-6399)
- Juliette O’Connell (ORCID: https://orcid.org/0000-0003-1114-9778)
- Ian Maidment (ORCID: https://orcid.org/0000-0003-4152-9704)
- Martin Henman (ORCID: https://orcid.org/0000-0002-7922-7691)
- Lamya Al Shuhaimi (ORCID: https://orcid.org/0000-0002-7142-7816)
- Caitríona M. Ryan (ORCID: https://orcid.org/0000-0001-7484-8635)
- Phyo Kyaw Myint (ORCID: https://orcid.org/0000-0003-3852-6158)
- Máire O’Dwyer (ORCID: https://orcid.org/0000-0002-1167-4903)
- Mary McCarron
Institutions
- Aston University (GB)
- University of Aberdeen (GB)
- Trinity College Dublin (IE)
- Temple University (US)
Publication Details
- Journal
- Journal of Intellectual Disability Research
- Published
- 2025-07-26
- DOI
- https://doi.org/10.1111/jir.70018
- Primary Topic
- Pharmaceutical Practices and Patient Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Trinity College Dublin